Evolent Health (EVH) Short-term Investments (2015 - 2026)

Evolent Health has reported Short-term Investments for 12 years, with the latest figure at $25.8 million in Q2 2026.

• On a quarterly basis, Short-term Investments fell 4.49% year-over-year to $25.8 million in Q2 2026; TTM through Jun 2026 was $25.8 million, a 4.49% decrease from a year earlier, with the FY2025 full-year figure at $28.8 million, down 61.18% from the prior year.
• Short-term Investments was $25.8 million for Q2 2026 at Evolent Health, down from $26.7 million in the prior quarter.
• The five-year high for Short-term Investments was $87.4 million in Q2 2022, with the low at $25.8 million in Q2 2026.
• Average Short-term Investments over 5 years is $41.8 million, with a median of $32.9 million recorded in 2023.
• The largest YoY upside for Short-term Investments was 180.58% in 2022 against a maximum downside of 69.59% in 2022.
• Over 5 years, Short-term Investments stood at $27.0 million in 2022, then climbed by 13.63% to $30.6 million in 2023, then surged by 142.53% to $74.3 million in 2024, then tumbled by 61.18% to $28.8 million in 2025, then declined by 10.67% to $25.8 million in 2026.
• The last three Short-term Investments figures came in at $25.8 million (Q2 2026), $26.7 million (Q1 2026), and $28.8 million (Q4 2025), per Business Quant data.